Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
FBIOP
FBIOP News & Events
-
Add to Watchlist
Trade FBIOP
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
FBIOP News
Fortress Biotech and Subsidiary Urica Therapeutics Report First Patient Doses in Crystalys Therapeutics' Global Phase 3 Trials of Dotinurad for Gout Treatment
Oct 21 2025
Newsfilter
Fortress Biotech and Urica Therapeutics Reveal $205 Million Series A Funding for Crystalys Therapeutics
Oct 01 2025
Newsfilter
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
May 30 2025
Newsfilter
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
May 15 2025
Newsfilter
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease
Jan 06 2025
Newsfilter
Fortress Biotech to Participate in October 2024 Investor Conferences
Sep 26 2024
Newsfilter
Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
Aug 13 2024
Newsfilter
Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027
Jul 25 2024
Newsfilter
Show More News
FBIOP Events
No data
FBIOP Monitor News
No data
FBIOP Earnings Analysis
No Data
People Also Watch
